Phlexglobal Announces Acquisition By Bridgepoint Development Capital

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AMERSHAM, England--(BUSINESS WIRE)--Phlexglobal, the specialist provider of innovative Trial Master File (TMF) and electronic Trial Master File (eTMF) expertise, solutions and services to the life sciences industry, announced today that it has been acquired by Bridgepoint Development Capital (‘BDC’).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC